Christopher Weil & Company

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 1, 2011	Vessix Vascular	$23.0M Series B	—	Andera Partners, DiNovA Capital, Fjord Invest, NeoMed Management, Vince Burgess
Oct 20, 2010	Vessix Vascular	$4.7M Other Equity	NeoMed Management	Olav Bergheim

Total Raised

N/A

Valuation

N/A

Key people at Christopher Weil & Company.

Laura Gordon

Key people at Christopher Weil & Company.

Laura Gordon